Applied DNA Sciences, Inc.
APDN
$3.26
$0.072.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 304.40K | 983.40K | 1.20M | 813.10K | 472.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 304.40K | 983.40K | 1.20M | 813.10K | 472.80K |
| Cost of Revenue | 299.30K | -- | 512.50K | 568.20K | 230.20K |
| Gross Profit | 5.10K | -- | 684.10K | 244.90K | 242.60K |
| SG&A Expenses | 2.93M | -- | 2.63M | 2.68M | 2.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.00M | 4.45M | 4.16M | 4.08M | 3.78M |
| Operating Income | -3.69M | -3.46M | -2.96M | -3.27M | -3.31M |
| Income Before Tax | -3.65M | -- | -2.67M | -3.31M | 1.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.65M | -- | -2.67M | -3.31M | 1.88M |
| Earnings from Discontinued Operations | -336.20K | -- | -- | -- | -33.80K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.70K | -- | 29.30K | 17.00K | 30.30K |
| Net Income | -3.95M | -3.30M | -2.64M | -3.30M | 1.88M |
| EBIT | -3.69M | -3.46M | -2.96M | -3.27M | -3.31M |
| EBITDA | -3.62M | -3.34M | -2.91M | -3.19M | -3.17M |
| EPS Basic | 20.20 | -230.31 | -417.53 | -240.01 | -- |
| Normalized Basic EPS | -3.92 | -- | -38.99 | -149.54 | -- |
| EPS Diluted | 20.20 | -230.31 | -417.53 | -240.01 | -- |
| Normalized Diluted EPS | -3.92 | -- | -38.99 | -149.54 | -- |
| Average Basic Shares Outstanding | 572.00K | 89.20K | 42.00K | 13.70K | -- |
| Average Diluted Shares Outstanding | 572.00K | 89.20K | 42.00K | 13.70K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |